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Abstract
Pneumonia caused by Pasteurella (Mannheimia) haemolytica was induced in weaned beef heifer calves,
approximately 6 months of age. Calves were treated at 20 h after challenge with therapeutic doses of
danofloxacin or tilmicosin. Peripheral blood neutrophils were collected at 3, 24 and 48 h after treatment. The
ex vivo effects on neutrophil function, neutrophil apoptosis, and hematological parameters were examined, as
was the effect on percentage lung consolidation. Neutrophil function assays included random migration under
agarose, cytochrome C reduction, iodination, Staphylococcus aureus ingestion, chemotaxis, and antibody-
dependent and antibody-independent cell-mediated cytotoxicity. Apoptosis was determined using a cell death
detection kit. Killing was performed at 72 h after treatment. Statistical comparisons were made among the
three groups of challenged–treated animals: saline, danofloxacin, and tilmicosin. Comparisons were also made
between nonchallenged nontreated animals (NCH) and challenged saline-treated animals. There were no
significant differences for any of the neutrophil function assays or neutrophil apoptosis among the
challenged–treated groups. This suggests that danofloxacin and tilmicosin have no clinically significant effects
on neutrophil function or apoptosis. There were also no significant differences in percentage lung
consolidation among the challenged–treated groups. Significant differences were found between the NCH
calves and the challenged saline-treated calves in several neutrophil assays, which were attributed to effects of
P. haemolyticainfection
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Pneumonia caused by Pasteurella (Mannheimia) haemolytica was induced in
weaned beef heifer calves, approximately 6 months of age. Calves were treated at
20 h after challenge with therapeutic doses of danofloxacin or tilmicosin.
Peripheral blood neutrophils were collected at 3, 24 and 48 h after treatment.
The ex vivo effects on neutrophil function, neutrophil apoptosis, and hematolog-
ical parameters were examined, as was the effect on percentage lung
consolidation. Neutrophil function assays included random migration under
agarose, cytochrome C reduction, iodination, Staphylococcus aureus ingestion,
chemotaxis, and antibody-dependent and antibody-independent cell-mediated
cytotoxicity. Apoptosis was determined using a cell death detection kit. Killing
was performed at 72 h after treatment. Statistical comparisons were made
among the three groups of challenged–treated animals: saline, danofloxacin, and
tilmicosin. Comparisons were also made between nonchallenged nontreated
animals (NCH) and challenged saline-treated animals. There were no significant
differences for any of the neutrophil function assays or neutrophil apoptosis
among the challenged–treated groups. This suggests that danofloxacin and
tilmicosin have no clinically significant effects on neutrophil function or
apoptosis. There were also no significant differences in percentage lung
consolidation among the challenged–treated groups. Significant differences were
found between the NCH calves and the challenged saline-treated calves in several
neutrophil assays, which were attributed to effects of P. haemolytica infection.
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INTRODUCTION
The effect of antimicrobials on immune function is a burgeoning
area of investigation in veterinary medicine. The authors have
previously reported that no significant differences were found
between two antimicrobials, danofloxacin and tilmicosin, on
circulating neutrophil function in healthy beef calves (Fajt et al.,
2000). This is in contrast to several in vitro studies that found
significant effects of various antimicrobials on bovine neutrophil
function, although the concentrations of antimicrobial applied to
the neutrophils were supra-therapeutic and therefore difficult to
extrapolate to the clinical setting (Ziv et al., 1983; Nickerson
et al., 1985; Paape & Miller, 1990; Paape et al., 1991; Hoeben
et al., 1997a,b, 1998).
As for diseased animals, calves with induced pneumonia
treated with tilmicosin prior to bacterial inoculation had an
increased incidence of apoptosis in neutrophils isolated from
the lungs (Chin et al., 1998). The significance of apoptosis of
neutrophils in bovine respiratory disease has not been well
established. Much of the damage that occurs to the lungs in
Pasteurella haemolytica pneumonia in cattle can be attributed to
the presence of neutrophils and their associated oxygen
radicals and enzymes (Slocombe et al., 1985; Breider et al.,
1986, 1988). However, dead or apoptotic neutrophils cannot
perform their microbicidal functions. The challenge in under-
standing the in vivo influence of antimicrobials on neutrophil
function in P. haemolytica pneumonia is the potential for the
bacteria themselves to affect neutrophil function, and the
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consequent difficulty in separating these effects from those of
the drug.
The purpose of this study was to investigate the effects of
danofloxacin and tilmicosin on the function of circulating
neutrophils and the extent of neutrophil apoptosis in the
presence of induced P. haemolytica pneumonia. Circulating
neutrophils are the source for recruitment of neutrophils to the
lung, and assay of their function should be indicative of
the functional ability of migrating neutrophils as they enter
the lung, avoiding the potential local, but not systemic, effects of
P. haemolytica. The other objective of this study was to evaluate
the abilities of the two antimicrobials to ameliorate the extent of
lung consolidation caused by P. haemolytica.
MATERIALS AND METHODS
The experimental protocol was approved by the Iowa State
University Committee on Animal Care.
Animals
Angus-cross heifers, approximately 6 months of age weighing
an average of 181.3 kg (SD ¼ 19.0) on arrival, were purchased
as a group from a single herd in Nebraska and shipped to allow
14 days of acclimation prior to the start of the study. Calves
had been vaccinated with modified live viral respiratory
vaccines; no Pasteurella vaccine was administered. There was
no history of treatment with fluoroquinolone or macrolide
antimicrobials prior to the start of the study. Animals were
housed outdoors in concrete-floored pens with open front sheds
as shelter, and were fed free choice hay and a grain supplement
containing monensin sodium at a rate of approximately
150 mg/head/day.
Bacterial challenge
A frozen ()70 C) stock culture of P. haemolytica A1 strain L101
isolated from a calf with pneumonia and then stored at )70 C
was used to prepare the inoculum as previously described, except
that the final incubation was for 3 h (Lehmkuhl et al., 1989).
The broth culture was then adjusted to an approximate
concentration of 1 · 108 cfu/mL. Concentrations of bacteria in
the inoculum were verified after the inoculation procedure with
standard plate counts.
An equine bronchoalveolar lavage catheter (Bivona, Inc.,
Gary, IN, USA) was passed through the nares into the trachea as
far as possible into a caudal lung lobe, then withdrawn
approximately 20 cm, and culture fluid (20 cc) was placed in
the catheter, followed by approximately 180 mL of air.
Selection criteria
Animals were randomly selected from a group of 48 for P.
haemolytica challenge, 18 during week 1 and 15 during week 2.
At 20 h after bacterial challenge, 12 animals displaying a rectal
temperature of ‡40 C and a clinical score of 1 or greater were
randomly selected each week for treatment, resulting in a total
of 24 challenged–treated animals (Animals not selected were
treated appropriately with an antimicrobial). The clinical
scoring system has been previously described (Perino & Apley,
1998), with a score of 0 – a normal animal, 1 – noticeable
depression without apparent signs of weakness, 2 – marked
depression with moderate signs of weakness without signifi-
cantly altered gait, 3 – severe depression with signs of weakness
such as significantly altered gait, and 4 – moribund and unable
to rise.
Each week, the 12 selected animals were sorted by tempera-
ture and grouped into blocks of three. A random number from a
uniform distribution on the interval (0, 1) was assigned to each
animal, and the animals were sorted within the four temperature
blocks by the random number. The first animal within each
block was assigned to saline, the second to danofloxacin, and the
third to tilmicosin.
Four animals were also selected each week at random to be
nonchallenged, nontreated controls (NCH), for a total of eight
NCH calves.
Clinical scoring
Clinical scoring was performed as described under selection
criteria at 0, 24, 48 and 72 h after treatment by an investigator
masked to treatment group identity.
Antimicrobials
Animals received one of the following treatments at 20 h after
bacterial challenge: danofloxacin mesylate (Advocin 180; Pfizer,
Inc., New York, NY, USA) (180 mg/mL) at a dose of 6 mg/kg
subcutaneously (s.c.) in the left lateral neck, tilmicosin (Micotil;
Elanco Animal Health, Indianapolis, IN, USA) (300 mg/mL) at a
dose of 10 mg/kg s.c. in the left lateral neck, or saline (0.9%) in a
volume equal to a dose of danofloxacin s.c. in the left lateral
neck.
Blood sampling
Blood samples were collected at 3, 24 and 48 h after treatment
for hematology and neutrophil isolation.
Hematology
Blood samples were collected via jugular venipuncture and
placed in tubes containing EDTA (Vacutainer; Becton Dickin-
son and Co., Franklin Lakes, NJ, USA). An automated cell
counter (Cell-Dyne 3500; Abbott Labs, Abbott Park, IL, USA)
was used to measure total and differential leukocyte count,
erythrocyte count, hematocrit, hemoglobin, mean corpuscular
volume (MCV), mean corpuscular hemoglobin (MCH), mean
corpuscular hemoglobin concentration (MCHC), red cell distri-
bution width (RDW), platelet count, and mean platelet
volume.
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Neutrophil isolation
Blood samples were collected via jugular venipuncture, and
neutrophils were isolated as previously described (Fajt et al.,
2000). Samples were suspended with Hanks balanced salt
solution to a concentration of 5 · 107 cells/mL for use in the
neutrophil assays.
Neutrophil assays
These assays have been previously described (Roth & Kaeberle,
1981a, 1994; Lukacs et al., 1985; Fajt et al., 2000). The assays
performed included random migration under agarose, cyto-
chrome C reduction, iodination, Staphylococcus aureus ingestion,
chemotaxis, and antibody-dependent and antibody-independent
cell-mediated cytotoxicity assay using radiolabeled (51Cr)
chicken erythrocytes.
Apoptosis was determined using a commercially available cell
death detection kit (Cell Death Detection ELISA; Roche Molecular
Biochemicals, Indianapolis, IN, USA). This kit is a sandwich
ELISA, using anti-histone antibody, test sample containing
nucleosomes, and anti-DNA peroxidase to measure photometri-
cally the amount of histone-associated DNA fragments generated
during apoptosis. Unstimulated levels of apoptosis were deter-
mined as was the percentage apoptosis after addition of
camptothecin (0.1 and 1.0 lg/mL), an apoptosis-inducing agent.
Lung lesions
Animals were killed with an overdose of barbiturate. At
necropsy, the lungs were removed from calves, and the
percentage of consolidation of each lobe was visually estimated.
Estimates were to the nearest 10%, except that lobes with <10%
but >0% consolidation were estimated as 5%. Previously
unpublished data (personal communication, Terry Skogerboe,
Pfizer Animal Health, 1998) derived from bovine lungs obtained
from a slaughterhouse were used to construct the following
formula to calculate total lung consolidation:
Total percentage lung consolidation ¼ (0.053 · cranial
segment of left cranial lobe %) + (0.049 · caudal segment
of left cranial lobe %) + (0.319 · left caudal lobe %) + (0.043 ·
accessory lobe %) + (0.352 · right caudal lobe %) + (0.061 ·
right middle lobe %) + (0.060 · caudal segment of right cranial
lobe %) + (0.063 · cranial segment of right cranial lobe %).
Areas of consolidation were sampled for histopathology and
bacterial culture.
Minimum inhibitory concentration determinations
Minimum inhibitory concentrations (MIC) of several antimicro-
bials were determined for P. haemolytica used for the bacterial
challenge as well as for P. haemolytica isolated from the lungs of
calves collected at necropsy. An automated broth-dilution
method was used to measure MICs (Sensititre; Trek Diagnostic
Systems, Westlake, OH, USA). Custom plates containing several
dilutions of the antimicrobials listed in Table 5 were used.
Statistical analysis
Unless otherwise stated, values reported are least-squares means
and standard errors (SEM). The following variables were natural
log transformed prior to analysis: neutrophil chemotactic index,
MCV, lymphocyte absolute count, monocyte absolute count,
RDW, mean platelet volume, and mononuclear white blood cell
count. The least-squares means were then back-transformed
after analysis. The repeatedly measured variables from the
challenged animals (three treatment groups) including the
neutrophil assay variables, apoptosis assay, and hematology
results, were analyzed using a general linear repeated-measures
mixed model (SAS Open VMS version 6.12 for an alpha, 1998;
SAS Institute, Inc., Cary, NC, USA). If a significant difference was
detected (P £ 0.05) due to day of study or treatment effect,
pairwise comparisons among treatments were made using
t-tests. Animals in the three challenged groups were blocked
by rectal temperature before treatments were assigned. Because
NCH calves could not be included in the blocking scheme with
the three challenged groups, they were compared only with
the saline-treated calves via t-test, which used the SE from the
statistical analysis of the challenged–treated groups. Statistical
significance was defined as P £ 0.05.
Calculations were performed for the neutrophil assays to
determine the power to determine a statistical difference at the
0.05 level (Stroup, 1999). Power was calculated for each
contrast performed within each neutrophil assay when no
significant differences were found. In addition, the least signifi-
cant difference required to detect a difference with 80% certainty
at the 0.05 level was calculated for each contrast.
Percentage lung consolidation data was transformed using the
arcsine square root transformation before analysis, and was then
analyzed using a general linear mixed model. Pairwise compar-
isons were made among treatments using the t-test if a significant
(P £ 0.05) treatment effect was found. After analysis, the least-
squares means were back-transformed for presentation.
RESULTS
Standard plate counts of the P. haemolytica challenge strain
revealed a concentration of 2.9 · 108 cfu/mL in the first group
and 1.7 · 108 cfu/mL in the second group of animals.
Of the 33 animals challenged with P. haemolytica, 28 exhibited
the selection criteria, and all selected calves had clinical scores of
1 or 2. By 72 h after treatment, just prior to killing, two calves in
the tilmicosin-treated group exhibited a clinical score of 0, with
all others remaining at 1 or 2, although there were no significant
differences among the treatment groups in body temperature
(data not shown).
Neutrophil assays
For all of the neutrophil function assays (random migration,
cytochrome C, iodination, S. aureus ingestion, chemotaxis, and
cytotoxicity), there was a significant day-of-collection effect.
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There were, however, no significant differences among the
challenged–treated groups (saline, danofloxacin, or tilmicosin-
treated) for any of the neutrophil function assays at 3, 24 or
48 h after treatment.
When the NCH calves were compared with the saline-treated
calves, there were no statistically significant differences between
the groups for the neutrophil chemotaxis assay, the iodination
assay, the unstimulated or stimulated cytochrome C reduction
assay, or the antibody-dependent cell-mediated cytotoxicity
assay.
Significant differences were found between the saline-treated
calves and the NCH calves for the following assays: neutrophil
random migration was significantly lower in the saline-treated
calves than in the NCH calves at 48 h after treatment (Table 1).
Neutrophils from the saline-treated calves displayed significantly
higher S. aureus ingestion percentage than neutrophils from NCH
calves at 24 h after treatment (Table 2). The percentage
antibody-independent cytotoxicity was significantly higher for
the saline-treated calves than for the NCH calves at 3 h after
treatment (Table 3). There were no other significant differences
between the saline-treated and the NCH calves.
There were no significant differences among the challenged–
treated groups or between the NCH and the saline-treated groups
for the cell death detection ELISA, whether apoptosis was
stimulated or not.
Hematology
There were no significant differences for total white blood cell
count or absolute neutrophil, lymphocyte, monocyte, eosinophil
or basophil counts among the challenged groups including
saline-treated calves. Total white count was significantly higher
for the saline-treated calves compared with the NCH calves at 24
and 48 h after treatment, for absolute neutrophil count at 3, 24,
and 48 h after treatment, and for absolute monocyte count at
24 and 48 h after treatment (see Table 4).
There were no significant differences among the challenged–
treated groups or between the NCH and the saline-treated
groups for total erythrocyte count, hemoglobin, MCV, MCH, or
RDW. The mean hematocrit for danofloxacin-treated
calves (31.5 ± 1.0%) was significantly lower than saline-
(35.5 ± 1.0%, P ¼ 0.006) or tilmicosin-treated (35.9 ± 1.0%,
P ¼ 0.002) calves at 24 h after treatment, and than that for
tilmicosin-treated calves at 48 h after treatment (29.7 ± 1.0%
vs. 32.5 ± 1.0%, P ¼ 0.05). The difference between saline-
(32.5 ± 1.0%) and danofloxacin-treated (29.7 ± 1.0%) calves
also approached significance at 48 h (P ¼ 0.0522), with
danofloxacin-treated calves being lower.
There were no significant differences among challenged–
treated groups or between NCH and saline-treated groups for
mean platelet volume. Total number of platelets did not differ
significantly among challenged–treated groups, but was signifi-
cantly lower at 3, 24 and 48 hours after treatment in the saline-
treated group compared with the NCH group (data not shown).
Lung consolidation and bacteriology
No significant differences for percentage of lung consolidation
were found among treatment groups or among blocks of animals
Table 1. The distance neutrophils migrated under agarose in a square
milliliter (neutrophil random migration assay). Neutrophils were
collected at 3, 24 and 48 h after treatment with danofloxacin, tilmicosin
or saline (approximately 23, 44 and 68 h after challenge with Pasteurella
haemolytica). NCH (nonchallenged group) is arithmetic mean; all other
groups are least-squares means. Statistical analysis was performed to
compare the three challenged–treated groups, and to compare NCH
calves with saline-treated calves. The lower portion of the table shows the
least significant difference (LSD) required between the challenged groups
to show a statistical difference, along with the statistical power to detect a
difference
Time after treatment 3 h 24 h 48 h
Saline 141.8 ± 15.1 47.5 ± 8.9 50.5 ± 8.7*
Danofloxacin 127.8 ± 15.1 38.9 ± 8.9 37 ± 8.7
Tilmicosin 106.5 ± 15.1 55.4 ± 8.9 46.3 ± 8.7
NCH 158.7 70.1 90.4*,
Contrast LSD (Power§) LSD (Power§) LSD (Power§)
Saline vs. danofloxacin 54.2 (0.11) 20.1 (0.23) 18.6 (0.54)
Saline vs. tilmicosin 54.2 (0.46) 20.1 (0.20) 18.6 (0.10)
Danofloxacin vs.
tilmicosin
54.2 (0.20) 20.1 (0.65) 18.6 (0.30)
*Differences significant at P £ 0.05.
SEs or CIs are not reported for the NCH group, because the SE used in
the statistical analysis was from the repeated measures analysis of
challenged–treated groups.
The absolute value of the difference in the least-squares means that
would be required to declare a statistically significant difference at the
0.05 level with 80% certainty.
§The likelihood of detecting a difference between the group mean at
P £ 0.05.
Table 2. Percent radiolabeled Staphylococcus aureus ingested by neu-
trophils (S. aureus ingestion assay). Neutrophils were collected at
3, 24 and 48 h after treatment with danofloxacin, tilmicosin or saline
(approximately 23, 44 and 68 h after challenge with Pasteurella
haemolytica). NCH is arithmetic mean; all other groups are least-squares
means with SEs. Statistical analysis was performed to compare the three
challenged–treated groups, and to compare NCH calves with saline-
treated calves. The lower portion of the table shows the least significant
difference required between the challenged groups to show a statistical
difference, along with the statistical power to detect a difference
Time after treatment 3 h 24 h 48 h
Saline 34.4 ± 2.3 29.6 ± 2.4* 18 ± 4.2
Danofloxacin 35.3 ± 2.3 30.9 ± 2.4 14 ± 4.2
Tilmicosin 34 ± 2.3 30.1 ± 2.4 18.4 ± 4.2
NCH 29.9 20.3*, 7.1
Contrast LSD (Power§) LSD (Power§) LSD (Power§)
Saline vs. danofloxacin 9.56 (0.06) 10.0 (0.07) 17.2 (0.10)
Saline vs. tilmicosin 9.56 (0.05) 10.0 (0.05) 17.2 (0.05)
Danofloxacin vs.
tilmicosin
9.56 (0.07) 10.0 (0.06) 17.2 (0.11)
See footnote of Table 1 for explanation of symbols.
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(blocked by temperature at the time of treatment). Total
percentage of lung consolidation in individual animals ranged
from 2.02 to 29.6%, with mean of 18.1, 14.7, and 13.0% for
saline, danofloxacin, and tilmicosin-treated animals, respectively.
Pasteurella haemolytica was isolated from seven of the eight
saline-treated, eight of the eight danofloxacin-treated, and five of
the eight tilmicosin-treated calves. Growth from one tilmicosin-
treated calf revealed no P. haemolytica, but low numbers of colonies
of S. epidermidis and P. multocida. The MICs for the challenge isolate
are shown in Table 5. The MICs for all of the lung isolates were the
same as the challenge inoculum with two exceptions: the MIC for
spectinomycin was 16 lg/mL for three isolates, and the MIC for
oxytetracycline was 64 lg/mL for two isolates, 1.0 lg/mL for one
isolate, and £ 0.5 lg/mL for three isolates.
Histopathologic examination of samples from all lungs
revealed changes consistent with subacute pneumonic pasteu-
rellosis such as foci of necrosis surrounded by necrotic
neutrophils, fibrinous bronchopneumonia, suppurative broncho-
pneumonia, and atelectasis.
DISCUSSION
The number of animals displaying the desirable clinical charac-
teristics after challenge with P. haemolytica (28 of 33 or 85%)
suggests that this induction model will continue to be useful in
pharmaceutical and other trials. As might be expected in the
clinical setting, some animals began to display clinical scores
of 0 by 72 h after treatment with an antimicrobial.
The lack of significant differences in the neutrophil function
assays in the challenged–treated groups is consistent with the
authors’ previous findings in healthy beef calves, where no
differences were noted for the same neutrophil function assays
among saline-, danofloxacin-, or tilmicosin-treated calves (Fajt
et al., 2000). As danofloxacin and tilmicosin administered to
healthy animals did not affect neutrophil function, it was
hypothesized that the addition of induced Pasteurella pneumonia
to the scheme should not affect neutrophil function differentially
between the two antimicrobials. These results are in contrast to
other researchers (Chin et al., 1998), who found that neutrophils
isolated from the lungs of tilmicosin-treated P. haemolytica-
challenged calves exhibited increased apoptosis at 3 h after
treatment compared with sham-treated animals (although there
were no differences at 24 h after treatment). One possibility is
Table 4. Total leukocyte counts showing statistically significant differ-
ences between saline-treated and NCH calves. Peripheral blood samples
were collected at 3, 24 and 48 h after treatment with saline (approxi-
mately 23, 44 and 68 h after challenge with Pasteurella haemolytica).
Total white count and neutrophil count mean are least-squares means
for saline-treated calves with SEs, and arithmetic mean for NCH calves.
Monocyte count mean are geometric mean and 95% CIs. Statistical
analysis was performed to compare the three challenged–treated groups,
and to compare NCH calves with saline-treated calves
Time after treatment 3 h 24 h 48 h
Total white count (thousands)
Saline 12.8 ± 1.7 12.4 ± 1.3* 10.9 ± 0.9*
NCH 8.4 6.8*, 7.6*,
Neutrophil count (thousands)
Saline 8.0 ± 1.2* 7.6 ± 1.0* 5.5 ± 0.7*
NCH 3.7*, 2.4*, 2.6*,
Monocyte count (thousands)
Saline 1.2 (1.0–1.6) 1.7 (1.3–2.2)* 1.7 (1.3–2.2)*
NCH 0.9 0.9*, 1.1*,
*Differences between saline-treated and NCH calves significant at
P £ 0.05.
Standard errors or CIs are not reported for the NCH group, because the
SE used in the statistical analysis was from the repeated measures ana-
lysis of challenged–treated groups.
Table 3. Percentage lysis of radiolabeled chicken erythrocytes (cRBC)
without anti-cRBC antibody. Neutrophils were collected at 3, 24 and
48 h after treatment with danofloxacin, tilmicosin or saline (approxi-
mately 23, 44 and 68 h after challenge with Pasteurella haemolytica).
NCH is arithmetic mean; all other groups are least-squares means with
SEs. Statistical analysis was performed to compare the three challenged–
treated groups, and to compare NCH calves with saline-treated calves.
The lower portion of the table shows the least significant difference
required between the challenged groups to show a statistical difference,
along with the statistical power to detect a difference
Time after treatment 3 h 24 h 48 h
Saline 20.5 ± 6.1* 10.2 ± 4.2 10.3 ± 3.9
Danofloxacin 21.6 ± 6.1 9.8 ± 4.2 13.1 ± 3.9
Tilmicosin 22.8 ± 6.1 11 ± 4.2 10.8 ± 3.9
NCH 2.3*, 1.4 0.7
Contrast LSD (Power§) LSD (Power§) LSD (Power§)
Saline vs. danofloxacin 22.6 (0.05) 13.4 (0.05) 12.0 (0.10)
Saline vs. tilmicosin 22.6 (0.06) 13.4 (0.05) 12.0 (0.05)
Danofloxacin vs.
tilmicosin
22.6 (0.05) 13.4 (0.06) 12.0 (0.08)
See footnote of Table 1 for explanation of symbols.
Table 5. Minimum inhibitory concentrations (MICs) in micrograms per
milliliter of the challenge inoculum of Pasteurella haemolytica to
antimicrobials, as evaluated using the Sensititre susceptibility testing
system
Antimicrobial MIC (lg/mL)
Amoxicillin/clavulanic acid £ 1.0/0.5
Cefquinome £ 0.06
Ceftiofur £ 0.06
Colistin £ 0.25
Danofloxacin 0.06
Enrofloxacin 0.03
Gentamicin £ 2.0
Oxytetracycline >64
Spectinomycin 32
Spiramycin 128
Tilmicosin 4
Trimethoprim/sulfadiazine 0.5/9.5
Tylosin 64
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the source of neutrophils: the Chin study used neutrophils
isolated from the lungs whereas this study examined circulating
neutrophils. It is also possible that the preinduction treatment
with tilmicosin in their study reduced the growth and metabo-
lism of P. haemolytica at 3 h after challenge, resulting in less
P. haemolytica-induced apoptosis, rather than a direct effect of
tilmicosin on neutrophil apoptosis.
It should be noted here that because concurrent pharmacoki-
netic studies would have been cost-prohibitive for the number of
animals in this trial, drug serum concentration data were not
gathered. However, because the doses used were as labeled on the
approved products, an assumption of ‘therapeutic concentrations’
was made; one of the purposes of this study was to assess effects of
the antimicrobials at labeled doses rather than at unattainable or
potentially toxic supratherapeutic doses. It is certainly possible,
although unlikely, that the lack of significant differences in the
neutrophil function assays was due to subtherapeutic concentra-
tions of antimicrobials. Given that the mean time-at-peak-
concentration (tmax) was 0.5 h for cattle given the same dose of
tilmicosin (but intramuscular) as in this study (Modric et al.,
1998) and 1 h for cattle given a slightly lower dose (5 mg/kg
rather than 6 mg/kg, also intramuscular) of danofloxacin (Mann
& Frame, 1992), and given that the mean elimination half-life in
those same studies was 30 h for tilmicosin (Modric et al., 1998)
and 2.9 h for danofloxacin (Mann & Frame, 1992), neutrophil
collection at 3 h represents a reasonable time to assess relatively
high concentrations of the antimicrobials, i.e., high within the
range of concentrations manifested at therapeutic dosages.
Because no significant differences were found among the
challenged–treated groups for the neutrophil assays, the power
to detect these differences was calculated. Using a reasonable
number of animals (eight per treatment group), the power
ranged from 0.05–0.65 depending on the assay. There are many
examples in the literature in which these assays had the power
to detect differences using eight to 10 animals (Coe et al., 1992;
Flaming et al., 1993, 1997). Because power is often not reported
in studies similar to this one, there is no basis for comparison.
However, taking into account the expensive nature of the
animals and the neutrophil assays as well as the laboratory
logistics, adding more subjects to the experimental design would
have been cost-prohibitive.
The only differences in the neutrophil function assays noted
among the groups were between the saline-treated and the NCH
calves. The fact that the only differences were between the
challenged-saline-treated calves and the NCH calves suggests
that these differences are caused by the P. haemolytica challenge,
not antimicrobial effects, perhaps as a result of circulating factors
associated with the infection as the neutrophils were collected
from the peripheral circulation. Challenged calves had higher
core body temperatures as measured via radiotelemetry (data not
shown), suggesting pro-inflammatory cytokine release, which
could effect changes in neutrophil function (Roth, 1994).
As expected, there were no significant differences among the
challenged–treated groups for the majority of the hematology
parameters, but there were significant differences between the
saline-treated and the NCH calves. The NCH calves were not
challenged with P. haemolytica and would therefore not be
expected to experience the increased leukocyte and neutrophil
count typically associated with this infection (Vestweber et al.,
1990). One exception to the lack of significant differences in
hematology was the lower hematocrit associated with the
danofloxacin-treated group, although the hematocrit remained
within normal limits for the laboratory (24–46%). This phe-
nomenon was also found in the authors’ previous report on
danofloxacin in healthy calves (Fajt et al., 2000), although it has
not been reported elsewhere for danofloxacin.
The other exception to the lack of significant differences among
groups in hematology was the finding of lower platelet counts in
saline-treated animals than in the NCH calves. This may be the
result of increased disappearance of platelets associated with the
pathophysiology of P. haemolytica infection, which results in
damage to endothelial cells, hemorrhage and therefore platelet
activation and subsequent microthrombosis (Weekly et al.,
1998). Other investigators found decreased platelet survival at
6 h postinoculation with P. haemolytica (Rashid et al., 1997).
The lack of significant differences among the challenged–
treated groups in percentage of lung consolidation can be partially
explained by the individual variability of consolidation. Using this
same induction model, the authors found a range of 5.0–37.5%
consolidation in nontreated animals (unpublished data). Addi-
tionally, the time of necropsy (72 h after treatment) may not have
allowed sufficient time for lesion healing that might have occurred
as a result of antimicrobial therapy, or sufficient time for lesions to
develop. It is also possible that the moderate infection produced by
this induction model did not allow significant differences to
manifest, whereas a more severe challenge model might have.
The changes in MICs from challenge inoculum to lung isolate
may be due to passage in the lungs. As no fingerprinting or
strain analysis was performed on the isolates, this could not be
confirmed. The MICs were similar enough across the majority of
antimicrobials; so the challenge strain was likely the same as the
isolated strain.
Overall, these results suggest that there are no major, clinically
significant effects of either danofloxacin or tilmicosin on circu-
lating neutrophil function and apoptosis in induced P. haemolytica
pneumonia. However, there is a significant effect of P. haemolytica
infection that results in changes in circulating neutrophil
function in the absence of antimicrobial administration.
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